RxDoctor Payments Data

Vanessa Pinter, DO

Family Medicine · Floyd, VANPI 1891140042

Payments from drug & device makers

$5,251in general payments, 2019–2025

Across 331 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$404
  • Pfizer$349
  • Amgen$341
  • Lilly USA, LLC$305
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,251 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$33,038
Medicare patients
106
Services billed
521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$32,692
JardianceEmpagliflozin33$29,705
FarxigaDapagliflozin Propanediol30$20,665
XareltoRivaroxaban21$15,460
EliquisApixaban25$14,467
LinzessLinaclotide20$10,629
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,865
TrintellixVortioxetine Hydrobromide12$5,778
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$4,623
MovantikNaloxegol Oxalate15$4,230
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic19$1,140
Levothyroxine Sodium164$1,099
Omeprazole69$902
Montelukast Sodium67$719
Gabapentin70$626

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,053$32,69226 claims
Boehringer IngelheimJardiance$162$29,70533 claims
AstraZenecaFarxiga$404$20,66530 claims
Johnson & JohnsonXarelto$177$15,46021 claims
PfizerEliquis$349$14,46725 claims
AbbVieLinzess$1,097$10,62920 claims
GSKTrelegy Ellipta$97$6,86511 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$56$5,77812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Floyd

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →